Floatz logo

Therapeutic Allogeneic Lymphocytes

Testicular Choriocarcinoma and Teratoma

National Cancer Institute (NCI)Cell therapyPhase 1Dormant
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
95/ 100

Competitive context

5 Active assets in the Testicular Choriocarcinoma and Teratoma cohort.

Asset / SponsorPhaseRating
Carboplatin
Children's Oncology Group
Phase 3BB
Carboplatin
Children's Oncology Group
Phase 3BB
BLEOMYCIN
Children's Oncology Group
Phase 3B
CIS-DIAMMINEDICHLOROPLATINUM II
Children's Oncology Group
Phase 3B
ETOPOSIDE
Children's Oncology Group
Phase 3B

View all 10 →

Same molecule, other indications

Therapeutic Allogeneic Lymphocytes is also rated in:

chronic myeloid leukemiaDormant
BBB
Indicative ·
72 / 100
View asset →
Relapsing Chronic Myelogenous LeukemiaDormant
BBB
Indicative ·
72 / 100
View asset →
myelodysplastic/myeloproliferative neoplasmDormant
BB
Indicative ·
70 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →